{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:55:46Z","timestamp":1773867346427,"version":"3.50.1"},"reference-count":42,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Myasthenia gravis (MG) is an autoimmune condition, that commonly impacts adult women of reproductive age. Myasthenia gravis in pregnancy is rare, but the incidence is higher in different geographical areas. Pregnancies in mothers with MG can have an unfortunate outcome. Acetylcholine receptor antibodies may pass into the fetal circulation and can affect the fetal neuromuscular junction, generating transient MG or even fetal arthrogryposis. The 2016 and 2021 International Consensus Guidance for Management of Myasthenia Gravis issued by Myasthenia Gravis Foundation of America is lacking in recommendation for fetal surveillance for pregnancies in women with MG. The aim of this paper is to highlight fetal and neonatal complications in mothers with MG and to offer antenatal care insights. Close maternal and pregnancy monitoring can improve pregnancy outcome. Patients with MG should be encouraged to conceive, to avoid triggers for exacerbations of the disease during pregnancy and a multidisciplinary team should be established to ensure the optimal support and therapy.<\/jats:p>","DOI":"10.3390\/medicina57111277","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:00:50Z","timestamp":1637528450000},"page":"1277","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fetal Surveillance in Pregnancies with Myasthenia Gravis"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9745-9891","authenticated-orcid":false,"given":"Br\u00eendu\u0219a Ana","family":"Cimpoca-Raptis","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Filantropia Clinical Hospital, 011132 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca Marina","family":"Ciobanu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Filantropia Clinical Hospital, 011132 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8425-6307","authenticated-orcid":false,"given":"Nicolae","family":"Gica","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Filantropia Clinical Hospital, 011132 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gheorghe","family":"Peltecu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Filantropia Clinical Hospital, 011132 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Mitrea","sequence":"additional","affiliation":[{"name":"Neuroaxis, Neurology Clinic, 011302 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca Maria","family":"Panaitescu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Filantropia Clinical Hospital, 011132 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"596621","DOI":"10.3389\/fneur.2020.596621","article-title":"Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies","volume":"11","author":"Frykman","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ncl.2018.01.005","article-title":"An Update: Myasthenia Gravis and Pregnancy","volume":"36","author":"Hamel","year":"2018","journal-title":"Neurol. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: A systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ciobanu, A.M., Dumitru, A.E., Gica, N., Botezatu, R., Peltecu, G., and Panaitescu, A.M. (2020). Benefits and Risks of IgG Transplacental Transfer. Diagnostics, 10.","DOI":"10.3390\/diagnostics10080583"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ar.1092360315","article-title":"Development of innervation of skeletal muscle fibers in man: Relation to acetylcholine receptors","volume":"236","author":"Hesselmans","year":"1993","journal-title":"Anat. Rec."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"581097","DOI":"10.3389\/fnmol.2020.581097","article-title":"The Structure, Function, and Physiology of the Fetal and Adult Acetylcholine Receptor in Muscle","volume":"13","author":"Cetin","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1172\/JCI117369","article-title":"Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor","volume":"94","author":"Lacokova","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/ene.13788","article-title":"Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence","volume":"25","author":"Gilhus","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","volume":"26","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fneur.2020.00554","article-title":"Myasthenia Gravis Can Have Consequences for Pregnancy and The Developing Child","volume":"11","author":"Gilhus","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Girotra, T., Baki, N., and Grover, K. (2016). Rituximab for Refractory Myasthenia Gravis in a Pregnant Patient (P2.165). Neurology, 86.","DOI":"10.1212\/WNL.86.16_supplement.P2.165"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-015-0332-8","article-title":"Immunosuppressive drugs and fertility","volume":"10","author":"Leroy","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp-2013-305572","article-title":"Myasthenia in pregnancy: Best practice guidelines from a U.K. multispecialty working group","volume":"85","author":"Norwood","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1331.2006.01538.x","article-title":"Myasthenia gravis in pregnancy and birth: Identifying risk factors, optimising care","volume":"14","author":"Hoff","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"History of thymoma and yellow fever vaccination","volume":"364","author":"Eidex","year":"2004","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2005.01.002","article-title":"Myasthenia gravis: Management issues during pregnancy","volume":"121","author":"Ferrero","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00003081-199103000-00012","article-title":"Myasthenia gravis in mothers and their newborns","volume":"34","year":"1991","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SMJ.0b013e31815d4398","article-title":"Myasthenia gravis crisis","volume":"101","author":"Bershad","year":"2008","journal-title":"South Med. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/adc.67.12.1442","article-title":"A randomised trial of low-dose folic acid to prevent neural tube defects","volume":"67","author":"Kirke","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"ref_23","unstructured":"Kachikis, A., Oler, E., Shree, R., Adams Waldorf, K., Hitti, J., and Eckert, L.O. (2019). Measles and the MMR Vaccine: Recommendations around Pregnancy, Including the Periconception and Postpartum Periods, Obstetric Consensus Statement; University of Washington."},{"key":"ref_24","unstructured":"(2021, October 29). Available online: https:\/\/www.cdc.gov\/vaccines\/pregnancy\/index.html."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1471-0528.1975.tb00710.x","article-title":"A critical evaluation of sonar \u201ccrown-rump length\u201d measurements","volume":"82","author":"Robinson","year":"1975","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.grf.0000153206.85996.07","article-title":"Myasthenia gravis and pregnancy","volume":"48","author":"Stafford","year":"2005","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/tera.1420510107","article-title":"Teratogenic potential of corticosteroids in humans","volume":"51","author":"Fraser","year":"1995","journal-title":"Teratology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-4","article-title":"Corticosteroids during pregnancy and oral clefts: A case-control study","volume":"58","year":"1998","journal-title":"Teratology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000511957","article-title":"Eculizumab during Pregnancy in a Patient with Treatment-Refractory Myasthenia Gravis: A Case Report","volume":"13","author":"Vu","year":"2021","journal-title":"Case Rep. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/uog.20284","article-title":"Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: Update of The Fetal Medicine Foundation results and meta-analysis","volume":"53","author":"Gil","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: Performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/1096-9926(200011)62:5<332::AID-TERA7>3.0.CO;2-E","article-title":"Teratogen update: Maternal myasthenia gravis as a cause of congenital arthrogryposis","volume":"62","author":"Polizzi","year":"2000","journal-title":"Teratology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01202412-199707000-00002","article-title":"Arthrogryposis multiplex congenita: Etiology, genetics, classification, diagnostic approach, and general aspects","volume":"6","author":"Hall","year":"1997","journal-title":"J. Pediatr. Orthop. B"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0960-5428(94)00041-L","article-title":"Aetiological factors in development of myasthenia gravis","volume":"4","author":"Vincent","year":"1994","journal-title":"Adv. Neuroimmunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1469-0705.1994.04050353.x","article-title":"Screening for fetal chromosomal abnormalities: Need to change the rules","volume":"4","author":"Nicolaides","year":"1994","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1080\/14767058.2017.1336220","article-title":"The first trimester combined test for aneuploidies\u2014A single center experience","volume":"31","author":"Veduta","year":"2018","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1196\/annals.1254.036","article-title":"Antibodies in myasthenia gravis and related disorders","volume":"998","author":"Vincent","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/EJA.0b013e32833e263f","article-title":"Myasthenia gravis and pregnancy: Anaesthetic management\u2014A series of cases","volume":"11","author":"Almeida","year":"2010","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_39","unstructured":"Lee, S., Webb, C., and Armstrong, S. (2021). Myasthenia Gravis and Pregnancy. ATOTW, 443. Available online: https:\/\/resources.wfsahq.org\/atotw\/myasthenia-gravis-and-pregnancy\/."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1212\/WNL.52.3.447","article-title":"Course and treatment of myasthenia gravis during pregnancy","volume":"52","author":"Batocchi","year":"1999","journal-title":"Neurology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/pd.1970130618","article-title":"Myasthenia gravis with polyhydramnios in the fetus of an asymptomatic mother","volume":"13","author":"Verspyck","year":"1993","journal-title":"Prenat. Diagn."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1080\/14767058.2017.1326904","article-title":"Maternal autoimmune disorders and fetal defects","volume":"31","author":"Panaitescu","year":"2018","journal-title":"J. Matern.-Fetal Neonatal Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/11\/1277\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:33:25Z","timestamp":1760168005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/11\/1277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["medicina57111277"],"URL":"https:\/\/doi.org\/10.3390\/medicina57111277","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,20]]}}}